Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | CRHBP | P24387 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.37 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 4/20 | 0.34 |
| ▸ | ESR1 | P03372 | 5/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 5/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13886632 | 1.00 | ALDH1A1 (0.43) | ALDH1A1L3MBTL1MAPTTDP1KDM4E | |
| SCHEMBL4650027 | 0.98 | L3MBTL1 (0.42) | ALDH1A1L3MBTL1MAPTTDP1KDM4E | |
| SCHEMBL36956 | 0.98 | L3MBTL1 (0.42) | ALDH1A1L3MBTL1MAPTTDP1KDM4E | |
| SCHEMBL13615638 | 0.96 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1MAPTTDP1KDM4E | |
| SCHEMBL13615742 | 0.96 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1MAPTTDP1KDM4E | |
| SCHEMBL12928332 | 0.96 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1MAPTTDP1KDM4E | |
| SCHEMBL14099683 | 0.96 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1MAPTTDP1KDM4E | |
| SCHEMBL12770707 | 0.96 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1MAPTTDP1KDM4E | |
| SCHEMBL13615687 | 0.96 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1MAPTTDP1KDM4E | |
| SCHEMBL12337529 | 0.96 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1MAPTTDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 732 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240244957-A1 | FORMULATION OF AN ORGANIC FUNCTIONAL MATERIAL | Merck Patent KGaA (DE) | 2024-07-18 | — | — | US | disclosed |
| US-12029120-B2 | Organic electroluminescence element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2024-07-02 | — | — | US | disclosed |
| US-12029120-B2 | Organic electroluminescence element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2024-07-02 | — | — | US | disclosed |
| WO-2024126635-A1 | FORMULATION OF AN ORGANIC FUNCTIONAL MATERIAL | MERCK PATENT GMBH (DE) | 2024-06-20 | — | — | WO | disclosed |
| WO-2024105066-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2024-05-23 | — | — | WO | disclosed |
| US-11917913-B2 | Substituted oxepines | MERCK PATENT GMBH (DE) | 2024-02-27 | — | — | US | disclosed |
| US-11917913-B2 | Substituted oxepines | MERCK PATENT GMBH (DE) | 2024-02-27 | — | — | US | disclosed |
| US-11917844-B2 | Organic EL element, and display apparatus, illumination apparatus, and moving object including the same | CANON KABUSHIKI KAISHA (JP) | 2024-02-27 | — | — | US | disclosed |
| US-11917844-B2 | Organic EL element, and display apparatus, illumination apparatus, and moving object including the same | CANON KABUSHIKI KAISHA (JP) | 2024-02-27 | — | — | US | disclosed |
| EP-4118697-B1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2024-01-24 | — | — | EP | disclosed |
| US-20070134512-A1 | Electroluminescent device containing an anthracene derivative | EASTMAN KODAK COMPANY | 2007-06-14 | — | — | US | disclosed |
| US-20070134512-A1 | Electroluminescent device containing an anthracene derivative | EASTMAN KODAK COMPANY | 2007-06-14 | — | — | US | disclosed |
| US-20070126347-A1 | OLEDS with improved efficiency | EASTMAN KODAK COMPANY | 2007-06-07 | — | — | US | disclosed |
| WO-2007050334-A1 | ORGANIC ELEMENT FOR LOW VOLTAGE ELECTROLUMINESCENT DEVICES | EASTMAN KODAK COMPANY (US) | 2007-05-03 | — | — | WO | disclosed |
| US-20070092759-A1 | Organic element for low voltage electroluminescent devices | GLOBAL OLED TECHNOLOGY LLC | 2007-04-26 | — | — | US | disclosed |
| US-20070092759-A1 | Organic element for low voltage electroluminescent devices | GLOBAL OLED TECHNOLOGY LLC | 2007-04-26 | — | — | US | disclosed |
| US-20070087222-A1 | Organic electroluminescence device | LG DISPLAY CO., LTD. (KR) | 2007-04-19 | — | — | US | disclosed |
| US-20070087222-A1 | Organic electroluminescence device | LG DISPLAY CO., LTD. (KR) | 2007-04-19 | — | — | US | disclosed |
| EP-1775334-A1 | Organic electroluminescence device | LG Electronics Inc. (KR) | 2007-04-18 | — | — | EP | disclosed |
| WO-2007021117-A1 | GREEN ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | GRACEL DISPLAY INC. (KR) | 2007-02-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11917913-B2 | Substituted oxepines | OXGR1, OXTR, OCIAD2 | ALDH1A1 1740/4885L3MBTL1 1480/4885MAPT 1547/4885 |
| US-12029120-B2 | Organic electroluminescence element and electronic device | RPS10, H1-10, OR10J3 | ALDH1A1 374/4885L3MBTL1 679/4885MAPT 3224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.